Recent employer surveys show: 19% of employers with 200+ employees cover GLP-1s for weight loss 43% of employers with 5,000+ employees provide coverage 64% of employers with 20,000+ employees offer coverage Large employers are increasingly viewing obesity as a chronic condition requiring long-term treatment strategies rather than short-term interventions
Clinical studies, including the STEP (Semaglutide GLP-1 Treatment Effect in People with Obesity) trials, have shown that participants experienced an average weight loss of about 15% over 68 weeks
Think of it like this: single agonist medications like semaglutide use one tool
If you encounter any serious side effects while taking Topamax, immediately inform your doctor
Movshovichs wife, Paulina, who wore blonde curls and studded blue jeans
Most people report that their hair tends to thin and may come out more frequently in the hairbrush, rather than leaving a bald spot